Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00638794 · ClinicalTrials.gov registry record
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
A clinical trial of Coronary Artery Disease, sponsored by Cardiovascular Research Foundation, New York.
- Completed
- Registry status
- 8,575
- Enrollment target
- 8
- Study locations
NCT00638794 is a study of Coronary Artery Disease that has completed, run by Cardiovascular Research Foundation, New York. The registered enrollment target is 8,575 participants, above the 1,248-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (587% higher). The trial reports 8 study locations across 6 states.
The verdict
NCT00638794, a study of Coronary Artery Disease, has completed, sponsored by Cardiovascular Research Foundation, New York.
- COMPLETED
- Registry status
- 8,575 participants
- Enrollment target
- 8
- Study locations
Study Summary
Prospective, multicenter, registry of at least 11,000 (and up to 15,000) consecutive patients with coronary artery disease undergoing stent-assisted percutaneous coronary intervention (PCI) using DES without major procedural complications.
Conditions Studied
Interventions
- DEVICE Drug -Eluting Stent (Taxus™, Cypher®, Endeavor™, Xience V™)
Study Locations (8)
North Carolina
- Carolinas Medical Center - Charlotte
- LeBauer Cardiovascular Research - Greensboro
- FirstHealth Moore Regional Hospital - Pinehurst
Minnesota
- Minneapolis Heart Institute - Minneapolis
New York
- Columbia University Medical Center & New York Presbyterian - New York
Ohio
- Ohio State University Medical Center - Columbus
Pennsylvania
- Lehigh Valley Hospital and Health Network - Allentown
Tennessee
- Wellmont Holston Valley Medical Center - Kingsport
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,575 participants |
| Start Date | 2008-01 |
| Est. Completion | 2013-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00638794
The ClinicalTrials.gov registry entry for NCT00638794 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 8,575 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,248-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (587% higher). The listed sponsor is Cardiovascular Research Foundation, New York, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Drug -Eluting Stent (Taxus™, Cypher®, Endeavor™, Xience V™) is the first listed.
NCT00638794 reports 8 study locations spanning 6 distinct geographic areas - top geographies include North Carolina, Minnesota, New York.
Frequently Asked Questions
What is clinical trial NCT00638794 about?
NCT00638794 is a clinical study titled "Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents". Prospective, multicenter, registry of at least 11,000 (and up to 15,000) consecutive patients with coronary artery disease undergoing stent-assisted percutaneous coronary intervention (PCI) using DES without major procedural complications.
What is the current status of trial NCT00638794?
This trial is currently completed. The enrollment target is 8,575 participants. The study started on 2008-01. Estimated completion is 2013-01.
What conditions does trial NCT00638794 study?
This clinical trial studies the following conditions: Coronary Artery Disease.
What interventions are being tested in trial NCT00638794?
The interventions under investigation include: Drug -Eluting Stent (Taxus™, Cypher®, Endeavor™, Xience V™) (DEVICE).
Who is sponsoring clinical trial NCT00638794?
This trial is sponsored by Cardiovascular Research Foundation, New York, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00638794 being conducted?
This trial has 8 study locations across Minnesota, New York, North Carolina, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Factors Affect Outcomes in Cardiovascular Surgery
RECRUITING
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.